17th Jun 2025 10:00
Dr. Martens plc (the 'Company')
Director / PDMR Shareholding
Notification of Transactions by Directors / Persons Discharging Managerial Responsibility
The Company announces that on 16 June 2025 the following directors / persons discharging managerial responsibility ('PDMR') were granted Performance Share Awards (the 'Awards') under the Company's Long Term Incentive Plan (the 'LTIP').
PDMR | Number of Shares |
Ije Nwokorie | 2,628,032 |
Giles Wilson | 2,019,743 |
As disclosed in the Company's 2025 Annual Report, the Awards will vest subject to the achievement of three equally weighted targets, namely cumulative earnings per share, relative total shareholder return and operating cash flow conversion, over three years. On vesting, the Awards will be subject to a further two-year holding period. No consideration was paid for the grant of the Award and no price is payable on the exercise of the Award.
Full details of the target ranges are set out in the Directors' Remuneration Report contained within the 2025 Annual Report & Accounts, which is available on the Company's website at www.drmartensplc.com.
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | Ije Nwokorie | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PDMR (Chief Executive Officer) | ||||||
b) | Initial notification/Amendment | Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Dr. Martens plc | ||||||
b) | LEI | 213800QPT8YM6NQZPH28 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||||
b) | Nature of the transaction | Grant of performance share award under the Dr. Martens Long Term Incentive Plan | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information
|
2,628,032 Nil | ||||||
e) | Date of the transaction | 16 June 2025 | ||||||
f) | Place of the transaction | Outside of a trading venue | ||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||
a) | Name | Giles Wilson | ||||||
2 | Reason for the notification | |||||||
a) | Position/status | PDMR (Chief Financial Officer) | ||||||
b) | Initial notification/Amendment | Initial notification | ||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
a) | Name | Dr. Martens plc | ||||||
b) | LEI | 213800QPT8YM6NQZPH28 | ||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01 ISIN: GB00BL6NGV24 | ||||||
b) | Nature of the transaction | Grant of performance share award under the Dr. Martens Long Term Incentive Plan | ||||||
c) | Price(s) and volume(s) |
| ||||||
d) | Aggregated information
|
2,019,743 Nil | ||||||
e) | Date of the transaction | 16 June 2025 | ||||||
f) | Place of the transaction | Outside of a trading venue | ||||||
For further information, please contact:Paul Rolling, Head of Secretariat+447584243562
Bethany Barnes, Director of Investor Relations+447825187465
ENDS
About Dr. Martens
Founded in 1960, Dr. Martens is an iconic British brand with a global presence. "Docs" or "DMs" were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history. It operates in over 60 countries and employs over 3,650 people worldwide. Its operations are split across both Direct-to-Consumer and wholesale channels, and in addition to its world-renowned "1460" boot its product segments span shoes including the 1461 shoe and Adrian loafer, sandals including the Zebzag mule, Kids ranges, as well as a growing line of bags and accessories. Further information can be found at https://www.drmartensplc.com/
Related Shares:
Dr. Martens